Management of Graves' hyperthyroidism and orbitopathy in time of COVID-19 pandemic.
作者信息
Bartalena L, Chiovato L, Marcocci C, Vitti P, Piantanida E, Tanda M L
机构信息
Endocrine Unit, Department of Medicine and Surgery, University of Insubria, ASST dei Sette Laghi, Viale Borri, 57, 21100, Varese, Italy.
Unit of Internal Medicine and Endocrinology, Laboratory for Endocrine Disruptors, Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy.
出版信息
J Endocrinol Invest. 2020 Aug;43(8):1149-1151. doi: 10.1007/s40618-020-01293-7. Epub 2020 May 21.
Abstract
摘要
相似文献
1
Management of Graves' hyperthyroidism and orbitopathy in time of COVID-19 pandemic.
J Endocrinol Invest. 2020 Aug;43(8):1149-1151. doi: 10.1007/s40618-020-01293-7. Epub 2020 May 21.
2
The dilemma of how to manage Graves' hyperthyroidism in patients with associated orbitopathy.
J Clin Endocrinol Metab. 2011 Mar;96(3):592-9. doi: 10.1210/jc.2010-2329. Epub 2010 Dec 29.
3
Graves' Disease.
N Engl J Med. 2016 Oct 20;375(16):1552-1565. doi: 10.1056/NEJMra1510030.
4
Outcome of very long-term treatment with antithyroid drugs in Graves' hyperthyroidism associated with Graves' orbitopathy.
Thyroid. 2011 Mar;21(3):279-83. doi: 10.1089/thy.2010.0181. Epub 2010 Dec 29.
5
Graves' hyperthyroidism of recent onset and Graves' orbitopathy: to ablate or not to ablate the thyroid?
J Endocrinol Invest. 2008 Jun;31(6):578-81. doi: 10.1007/BF03346411.
6
Sustained control of Graves' hyperthyroidism during long-term low-dose antithyroid drug therapy of patients with severe Graves' orbitopathy.
Thyroid. 2011 Sep;21(9):951-6. doi: 10.1089/thy.2011.0039. Epub 2011 Aug 11.
7
Asymmetric Graves' Orbitopathy.
Front Endocrinol (Lausanne). 2020 Dec 17;11:611845. doi: 10.3389/fendo.2020.611845. eCollection 2020.
8
Childhood Graves' ophthalmopathy: results of a European questionnaire study.
Eur J Endocrinol. 2005 Oct;153(4):515-21. doi: 10.1530/eje.1.01991.
9
Effects of treatment modalities for Graves' hyperthyroidism on Graves' orbitopathy: a 2015 Italian Society of Endocrinology Consensus Statement.
J Endocrinol Invest. 2015 Apr;38(4):481-7. doi: 10.1007/s40618-015-0257-z. Epub 2015 Feb 27.
10
[Graves' ophthalmopathy from the internist's perspective].
Ophthalmologe. 2011 May;108(5):410-6. doi: 10.1007/s00347-010-2185-9.
引用本文的文献
1
The effect of COVID-19 process on patients with endocrinological disease in a pandemic hospital: What happened to the others?
Arch Endocrinol Metab. 2023 Jan 18;67(1):45-54. doi: 10.20945/2359-3997000000525. Epub 2022 Oct 11.
2
Potential relationships between COVID-19 and the thyroid gland: an update.
J Int Med Res. 2022 Feb;50(2):3000605221082898. doi: 10.1177/03000605221082898.
3
SARS-CoV-2: Emerging Role in the Pathogenesis of Various Thyroid Diseases.
J Inflamm Res. 2021 Nov 24;14:6191-6221. doi: 10.2147/JIR.S332705. eCollection 2021.
4
Management of thyroid disorders during the COVID-19 outbreak: a position statement from the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism (SBEM).
Arch Endocrinol Metab. 2021 Nov 3;65(3):368-375. doi: 10.20945/2359-3997000000352. Epub 2021 Apr 12.
5
Thyroid and COVID-19: a review on pathophysiological, clinical and organizational aspects.
J Endocrinol Invest. 2021 Sep;44(9):1801-1814. doi: 10.1007/s40618-021-01554-z. Epub 2021 Mar 25.
6
Association of Other Autoimmune Diseases With Thyroid Eye Disease.
Front Endocrinol (Lausanne). 2021 Mar 5;12:644200. doi: 10.3389/fendo.2021.644200. eCollection 2021.
7
Impact of COVID-19 on the thyroid gland: an update.
Rev Endocr Metab Disord. 2021 Dec;22(4):803-815. doi: 10.1007/s11154-020-09615-z. Epub 2020 Nov 25.
8
Thyroid disorders and SARS-CoV-2 infection: From pathophysiological mechanism to patient management.
Ann Endocrinol (Paris). 2020 Oct;81(5):507-510. doi: 10.1016/j.ando.2020.09.001. Epub 2020 Sep 18.
9
Management of Graves Thyroidal and Extrathyroidal Disease: An Update.
J Clin Endocrinol Metab. 2020 Dec 1;105(12):3704-20. doi: 10.1210/clinem/dgaa646.
10
Thyroid surgery during coronavirus-19 pandemic phases I, II and III: lessons learned in China, South Korea, Iran and Italy.
J Endocrinol Invest. 2021 May;44(5):1065-1073. doi: 10.1007/s40618-020-01407-1. Epub 2020 Sep 2.
本文引用的文献
1
COVID-19 infection and glucocorticoids: update from the Italian Society of Endocrinology Expert Opinion on steroid replacement in adrenal insufficiency.
J Endocrinol Invest. 2020 Aug;43(8):1141-1147. doi: 10.1007/s40618-020-01266-w. Epub 2020 Apr 25.
2
An invisible hand has guided clinical endocrinology toward an unexpected future.
J Endocrinol Invest. 2020 Jul;43(7):1037-1038. doi: 10.1007/s40618-020-01256-y. Epub 2020 Apr 20.
3
COVID-19 and endocrine diseases. A statement from the European Society of Endocrinology.
Endocrine. 2020 Apr;68(1):2-5. doi: 10.1007/s12020-020-02294-5.
4
Safety of long-term antithyroid drug treatment? A systematic review.
J Endocrinol Invest. 2019 Nov;42(11):1273-1283. doi: 10.1007/s40618-019-01054-1. Epub 2019 May 27.
5
Primary therapy of Graves' disease and cardiovascular morbidity and mortality: a linked-record cohort study.
Lancet Diabetes Endocrinol. 2019 Apr;7(4):278-287. doi: 10.1016/S2213-8587(19)30059-2. Epub 2019 Feb 28.
6
2018 European Thyroid Association Guideline for the Management of Graves' Hyperthyroidism.
Eur Thyroid J. 2018 Aug;7(4):167-186. doi: 10.1159/000490384. Epub 2018 Jul 25.
7
Antithyroid drug treatment for Graves' disease: baseline predictive models of relapse after treatment for a patient-tailored management.
J Endocrinol Invest. 2018 Dec;41(12):1425-1432. doi: 10.1007/s40618-018-0918-9. Epub 2018 Jun 26.
8
Thyroid Storm: A Japanese Perspective.
Thyroid. 2018 Jan;28(1):32-40. doi: 10.1089/thy.2017.0243. Epub 2017 Oct 5.
9
Increased risk for thionamide-induced agranulocytosis in elderly patients: a case presentation and literature review.
BMJ Case Rep. 2017 Jul 17;2017:bcr-2017-220924. doi: 10.1136/bcr-2017-220924.
10
Excess Mortality in Treated and Untreated Hyperthyroidism Is Related to Cumulative Periods of Low Serum TSH.
J Clin Endocrinol Metab. 2017 Jul 1;102(7):2301-2309. doi: 10.1210/jc.2017-00166.
Zotero 插件